Cargando…
The adoption of nintedanib in systemic sclerosis: the SENSCIS study
Nintedanib shows a statistically significant effect on lung function decay in patients with ILD secondary to systemic sclerosis, but no effect on skin fibrosis and on health-related quality of life http://bit.ly/2vfJRj7
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341613/ https://www.ncbi.nlm.nih.gov/pubmed/32665787 http://dx.doi.org/10.1183/20734735.0005-2020 |
| _version_ | 1783555274585407488 |
|---|---|
| author | Bruni, Teresa Varone, Francesco |
| author_facet | Bruni, Teresa Varone, Francesco |
| author_sort | Bruni, Teresa |
| collection | PubMed |
| description | Nintedanib shows a statistically significant effect on lung function decay in patients with ILD secondary to systemic sclerosis, but no effect on skin fibrosis and on health-related quality of life http://bit.ly/2vfJRj7 |
| format | Online Article Text |
| id | pubmed-7341613 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73416132020-07-13 The adoption of nintedanib in systemic sclerosis: the SENSCIS study Bruni, Teresa Varone, Francesco Breathe (Sheff) Expert Opinion Nintedanib shows a statistically significant effect on lung function decay in patients with ILD secondary to systemic sclerosis, but no effect on skin fibrosis and on health-related quality of life http://bit.ly/2vfJRj7 European Respiratory Society 2020-06 /pmc/articles/PMC7341613/ /pubmed/32665787 http://dx.doi.org/10.1183/20734735.0005-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Expert Opinion Bruni, Teresa Varone, Francesco The adoption of nintedanib in systemic sclerosis: the SENSCIS study |
| title | The adoption of nintedanib in systemic sclerosis: the SENSCIS study |
| title_full | The adoption of nintedanib in systemic sclerosis: the SENSCIS study |
| title_fullStr | The adoption of nintedanib in systemic sclerosis: the SENSCIS study |
| title_full_unstemmed | The adoption of nintedanib in systemic sclerosis: the SENSCIS study |
| title_short | The adoption of nintedanib in systemic sclerosis: the SENSCIS study |
| title_sort | adoption of nintedanib in systemic sclerosis: the senscis study |
| topic | Expert Opinion |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341613/ https://www.ncbi.nlm.nih.gov/pubmed/32665787 http://dx.doi.org/10.1183/20734735.0005-2020 |
| work_keys_str_mv | AT bruniteresa theadoptionofnintedanibinsystemicsclerosisthesenscisstudy AT varonefrancesco theadoptionofnintedanibinsystemicsclerosisthesenscisstudy AT bruniteresa adoptionofnintedanibinsystemicsclerosisthesenscisstudy AT varonefrancesco adoptionofnintedanibinsystemicsclerosisthesenscisstudy |